Starry Sea Acquisition Corp (SSEA) · Oct 20, 2026 · Other events
Deadline extended — November 7, 2026 to November 7, 2027, one month at a time
Starry Sea Acquisition’s shareholder vote extends its business-combination deadline to November 2027, buying more time but adding no operating progress.
Starry Sea is a blank-check company trying to complete its announced SuperiorMed healthcare merger, with the transaction still dependent on shareholder, regulatory, and other closing conditions. The filing keeps the SPAC alive rather than advancing the merger itself. Shareholders approved extending the combination period from November 7, 2026 to November 7, 2027, in up to twelve one-month increments. 〔0〕 This removes the immediate liquidation deadline, but it does not show that the target transaction is closer to closing.
The extension is funded month by month and carries a mechanical backstop. For each month, the sponsor or its designees must deposit the lesser of $60,000 or $0.033 per remaining public share into the trust account. If the payment is not made and remains uncured for 30 days, public shares are automatically redeemed. 〔1〕 The framework was already disclosed in the proxy materials, so the vote mainly confirms the expected path rather than delivering a new business development.
Bottom line: SSEA has bought up to another year to complete its business combination, but the filing changes the timetable—not the underlying execution status of the merger. It is a survival extension, not evidence that the deal is advancing.
Monthly extension deposit and merger-closing process
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!